FrancophonIA/ELRC3.0 huggingface dataset:
English: Some patients who experience decrease in their response may benefit from an increase in dosing frequency to 40 mg SOLYMBIC every week.
Croatian: U nekih bolesnika u kojih dođe do slabljenja odgovora na terapiju možda će biti korisno povećati učestalost doziranja na 40 mg lijeka SOLYMBIC svaki tjedan.
English: The recommended SOLYMBIC induction dose regimen for paediatric subjects with severe Crohn's disease is 80 mg at week 0 followed by 40 mg at week 2.
Croatian: Preporučena indukcijska doza lijeka SOLYMBIC u pedijatrijskih bolesnika s teškom Crohnovom bolesti je 80 mg u nultom tjednu i 40 mg u drugom tjednu.
English: Each pre-filled syringe contains 40 mg of adalimumab in 0.8 mL of solution.
Croatian: Svaka napunjena brizgalica sadrži 40 mg adalimumaba u 0,8 ml otopine.
English: The usual dose for adults with psoriasis is an initial dose of 80 mg, followed by 40 mg given every other week starting one week after the initial dose.
Croatian: Uobičajena doza za odrasle bolesnike sa psorijazom je početna doza od 80 mg, nakon čega slijedi 40 mg svaki drugi tjedan počevši tjedan dana nakon početne doze.
English: Vertigo and visual impairment may occur following administration of SOLYMBIC (see section 4.8).
Croatian: Nakon primjene lijeka SOLYMBIC mogu se pojaviti vrtoglavica i poremećaji vida (vidjeti dio 4.8).
English: Each pre-filled syringe contains 20 mg of adalimumab in 0.4 mL of solution.
Croatian: Jedna napunjena štrcaljka sadrži 20 mg adalimumaba u 0,4 ml otopine.
English: EU/1/16/1163/009 - 6 pack
Croatian: EU/1/16/1163/009 - 6 pakiranja
English: EU/1/16/1163/005 - 6 pack
Croatian: EU/1/16/1163/005 - 6 pakiranja
English: EU/1/16/1163/007 - 2 pack
Croatian: EU/1/16/1163/007 - 2 pakiranja
English: In case there is a need for a more rapid response to therapy, the regimen 160 mg at week 0 (dose can be administered as four injections in one day or as two injections per day for two consecutive days), 80 mg at week 2, can be used with the awareness that the risk for adverse events is higher during induction.
Croatian: U slučaju da postoji potreba za bržim odgovorom na terapiju, terapija se može započeti dozom od 160 mg u nultom tjednu (lijek se može dati kao četiri injekcije u jednom danu ili kao dvije injekcije na dan kroz dva uzastopna dana) i 80 mg u drugom tjednu, uz napomenu da je rizik od razvoja nuspojava veći prilikom indukcije.
English: Belly
Croatian: Bedro
English: SOLYMBIC 20 mg solution for injection in pre-filled syringe adalimumab
Croatian: SOLYMBIC 20 mg otopina za injekciju u napunjenoj štrcaljki adalimumab
English: Depending on your response, your doctor may increase the dose frequency to 40 mg every week.
Croatian: Ovisno o odgovoru na terapiju, Vaš liječnik Vam može povećati učestalost doziranja na 40 mg svaki tjedan.
English: SOLYMBIC 40 mg solution for injection in pre-filled syringe.
Croatian: SOLYMBIC 40 mg otopina za injekciju u napunjenoj štrcaljki.
English: Vaccinations: if possible children should be up to date with all vaccinations before using SOLYMBIC.
Croatian: • Cijepljenje: ako je moguće, preporučuje se da djeca obave sva cijepljenja prema važećim smjernicama prije započinjanja terapije lijekom SOLYMBIC.
English: Continued therapy should be carefully reconsidered in a patient not responding within this time period.
Croatian: Ako se unutar tog razdoblja ne postigne terapijski odgovor, valja pažljivo razmotriti nastavak liječenja takvog bolesnika.
English: EU/1/16/1163/004 - 4 pack
Croatian: EU/1/16/1163/004 - 4 pakiranja
English: EU/1/16/1163/008 - 4 pack
Croatian: EU/1/16/1163/008 - 4 pakiranja
English: If a faster response is required, your doctor may prescribe an initial dose of 160 mg (as four 40 mg injections in one day or two 40 mg injections per day for two consecutive days), followed by 80 mg two weeks later, and thereafter as 40 mg every other week.
Croatian: Ako je potreban brži odgovor na liječenje, liječnik Vam može propisati početnu dozu od 160 mg (4 injekcije od 40 mg u jednom danu ili 2 injekcije od 40 mg u dva uzastopna dana) i zatim 80 mg nakon dva tjedna.
English: In patients with hidradenitis suppurativa, a dose of 160 mg adalimumab on week 0 followed by 80 mg on week 2 achieved serum adalimumab trough concentrations of approximately 7 to 8 μg/mL at week 2 and week 4.
Croatian: Nakon primjene adalimumaba u dozi od 160 mg u nultom tjednu i 80 mg u 2. tjednu u bolesnika s gnojnim hidradenitisom, najniže koncentracije adalimumaba u serumu u 2. i 4. tjednu iznosile su približno 7 do 8 µg/ml.
English: There is no relevant use of adalimumab in the paediatric population in the indications, ankylosing spondylitis and psoriatic arthritis.
Croatian: Psorijatični artritis i aksijalni spondiloartritis, uključujući ankilozantni spondilitis Nema relevantne primjene adalimumaba u djece u indikacijama ankilozantnog spondilitisa i psorijatičnog artritisa.
English: EU/1/16/1163/003 - 2 pack
Croatian: EU/1/16/1163/003 - 2 pakiranja
English: SOLYMBIC 40 mg solution for injection in pre-filled syringe adalimumab
Croatian: SOLYMBIC 40 mg otopina za injekciju u napunjenoj štrcaljki adalimumab
English: The usual SOLYMBIC dose for adults with ulcerative colitis is 160 mg initially (dose can be administered as four 40 mg injections in one day or as two 40 mg injections per day for two consecutive days) followed by 80 mg two weeks later, then 40 mg every other week.
Croatian: Uobičajena početna doza lijeka SOLYMBIC za odrasle bolesnike s ulceroznim kolitisom je 160 mg (4 injekcije od 40 mg u jednom danu ili 2 injekcije od 40 mg u dva uzastopna dana), nakon čega poslije dva tjedna slijedi doza od 80 mg.
English: RA study III
Croatian: Ispitivanje RA II a** Ispitivanje RA III a**
English: LABEL PRE-FILLED SYRINGE
Croatian: Opstrukcija tankog crijeva
English: • Patient information pack
Croatian: • Edukacijske materijale za bolesnika
English: Ankylosing spondylitis and axial spondyloarthritis without radiographic evidence of ankylosing spondylitis
Croatian: Ankilozantni spondilitis i aksijalni spondiloartritis bez radiološkog dokaza AS-a
English: The recommended dose of SOLYMBIC for adult patients with uveitis is an initial dose of 80 mg, followed by 40 mg given every other week starting one week after the initial dose.
Croatian: Preporučena doza lijeka SOLYMBIC u odraslih bolesnika s uveitisom je početna doza od 80 mg, nakon koje slijedi doza od 40 mg svaki drugi tjedan, počevši tjedan dana nakon početne doze.
English: The usual dose for adults with non-infectious uveitis is an initial dose of 80 mg, followed by 40 mg given every other week starting one week after the initial dose.
Croatian: Uobičajena doza za odrasle s nezaraznim uveitisom je početna doza od 80 mg, nakon čega slijedi doza od 40 mg svaki drugi tjedan, počevši tjedan dana nakon početne doze.
English: paleness.
Croatian: SOLYMBIC.
English: Neuropathy
Croatian: NPc
English: Using your SOLYMBIC pre-filled pen
Croatian: Primjena SOLYMBIC napunjene brizgalice
English: Advise your doctor if you have a history of recurrent infections or other conditions that increase the risk of infections.
Croatian: Ako ste ranije bolovali od infekcija koje su se ponavljale, ili drugih stanja koja povisuju rizik od infekcije, recite to svom liječniku.
English: The recommended dose of SOLYMBIC for adult patients is an initial dose of 80 mg administered subcutaneously, followed by 40 mg subcutaneously given every other week starting one week after the initial dose.
Croatian: U odraslih bolesnika preporučena početna doza lijeka SOLYMBIC je 80 mg supkutano, nakon čega slijedi 40 mg supkutano svaka dva tjedna, počevši jedan tjedan nakon početne doze.
English: Undesirable effects in paediatric patients
Croatian: Nuspojave u pedijatrijskoj populaciji
English: What SOLYMBIC contains - The active substance is adalimumab.
Croatian: Djelatna tvar je adalimumab.
English: If you have ankylosing spondylitis or axial spondyloarthritis without radiographic evidence of ankylosing spondylitis, you will first be given other medicines.
Croatian: Ako bolujete od ankilozantnog spondilitisa ili aksijalnog spondiloartritisa bez radiološkog dokaza AS-a, prvo će Vam biti dani drugi lijekovi, no ukoliko na njih ne reagirate dovoljno dobro, bit će Vam propisan lijek SOLYMBIC kako bi se smanjili simptomi i znakovi Vaše bolesti.
English: Table 20 Paediatric CD study PCDAI clinical remission and response
Croatian: Tablica 20 Ispitivanje kod Crohnove bolesti u djece PCDAI klinička remisija i odgovori Standardna doza 40/20 mg svaki drugi
English: SOLYMBIC 40 mg solution for injection in a pre-filled pen adalimumab
Croatian: SOLYMBIC 40 mg otopina za injekciju u napunjenoj brizgalici adalimumab
English: B. Inspect the SOLYMBIC pre-filled pen.
Croatian: Pregledajte SOLYMBIC napunjenu brizgalicu.
English: Adalimumab 40 mg eow N = 109
Croatian: Adalimumab 40 mg svaki drugi tjedan N=109
English: • itchy rash;
Croatian: • isprekidan san,
English: Intestinal perforation
Croatian: Kirurški zahvati
English: Room spinning sensation and vision disturbances may occur after taking SOLYMBIC.
Croatian: Nakon uzimanja lijeka SOLYMBIC može se javiti osjećaj da se prostorija vrti te smetnje vida.
English: swelling or rash do not inject more SOLYMBIC and contact your doctor immediately since, in rare cases, these reactions can be life threatening.
Croatian: • Razvijete li alergijske reakcije sa simptomima poput stezanja u prsnom košu, ''piskanja pri disanju'', omaglice, oticanja ili osipa, prestanite ubrizgavati lijek SOLYMBIC i odmah se javite liječniku, jer te reakcije u rijetkim slučajevima mogu biti opasne po život.
English: Non-infectious uveitis is an inflammatory disease affecting certain parts of the eye. SOLYMBIC is used to treat adults with non-infectious uveitis with inflammation affecting the back of the eye.
Croatian: SOLYMBIC je namijenjen liječenju odraslih osoba s nezaraznim uveitisom kod kojega upala zahvaća stražnji dio oka.
English: You might get infections more easily while you are receiving SOLYMBIC treatment.
Croatian: • Dok primate lijek SOLYMBIC, možete biti podložniji infekcijama.
English: All patients should be advised to seek immediate medical attention if they develop signs and symptoms suggestive of blood dyscrasias
Croatian: Bolesnike treba upozoriti da se odmah obrate liječniku ako se za vrijeme liječenja lijekom SOLYMBIC pojave znakovi i simptomi koji upućuju na krvne diskrazije (npr. stalna vrućica, stvaranje (nastanak) modrica, krvarenje, bljedilo).
English: SOLYMBIC 40 mg solution for injection in pre-filled pen.
Croatian: SOLYMBIC 40 mg otopina za injekciju u napunjenoj brizgalici.
English: Table 3 Undesirable effects
Croatian: Tablica 3 Nuspojave
English: Leucocytosis, Thrombocytopaenia Uncommon Idiopathic thrombocytopaenic purpura Rare
Croatian: vrlo često leukopenija (uključujući neutropeniju i agranulocitozu), anemija često leukocitoza, trombocitopenija manje često idiopatska trombocitopenična purpura rijetko pancitopenija
English: The mean steady-state trough concentration at week 12 through week 36 were approximately 8 to 10 μg/mL during adalimumab 40 mg every week treatment.
Croatian: Kada se adalimumab primjenjivao u dozi od 40 mg svaki tjedan, srednja vrijednost najniže koncentracije u stanju dinamičke ravnoteže od 12. do 36. tjedna iznosila je približno 8 do 10 µg/ml.
English: RA study II
Croatian: Ispitivanje RA I a**
English: • ear infections;
Croatian: • infekcije uha,
English: • acid reflux disease;
Croatian: • bolest vraćanja kiselog sadržaja iz želuca,
English: All of the studies lasted for a year (13 four-week cycles).
Croatian: Sva su ispitivanja trajala godinu dana (13 četverotjednih ciklusa).
English: Its safety and effectiveness have been studied in women aged 18 to 45 years.
Croatian: Sigurnost primjene i djelotvornost lijeka ispitivane su u žena u dobi od 18 do 45 godina.
English: The full EPAR for Evra can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Croatian: Cjeloviti EPAR za lijek Evra nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
English: What is Evra and what is it used for?
Croatian: Što je Evra i za što se koristi?
English: What measures are being taken to ensure the safe and effective use of Evra?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Evra?
English: The patch-free interval must not be longer than seven days; otherwise, additional nonhormonal contraceptive methods must be used, such as condoms.
Croatian: Razdoblje bez primjene flastera ne smije biti dulje od sedam dana; u protivnom moraju se primijeniti dodatne nehormonske metode kontracepcije, poput prezervativa.
English: This gives Evra a ‘Pearl Index' of 0.90.
Croatian: To znači da Evra ima Pearlov indeks od 0,90.
English: Evra has been shown to be an effective contraceptive.
Croatian: Dokazano je da je Evra djelotvoran kontraceptiv.
English: Evra may work less well in women weighing 90 kg or more.
Croatian: Evra će možda djelovati slabije u žena koje teže 90 kg ili više.
English: Five of the pregnancies were in women weighing over 90 kg.
Croatian: Pet trudnoća nastupilo je u žena težih od 90 kg.
English: Evra norelgestromin / ethinylestradiol
Croatian: Evra norelgestromin / etinilestradiol
English: The same area of skin should not be used for two consecutive patches.
Croatian: Ne smiju se stavljati na isto područje kože dva puta uzastopno.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Evra on 22 August 2002.
Croatian: Europska komisija izdala je odobrenje za stavljanje lijeka Evra u promet koje vrijedi na prostoru Europske unije od 22. kolovoza 2002.
English: It was studied in three main studies in over 3,000 women, which determined the number of women who became pregnant while taking the medicine.
Croatian: Proučavan je u trima glavnim ispitivanjima kojima je bilo obuhvaćeno više od 3 000 žena, a cilj je bio utvrditi broj žena koje su zatrudnjele dok su uzimale lijek.
English: Ethinylestradiol has been in use extensively in oral contraceptives for many years, and norelgestromin is very similar to another progestogen, which is also used in some oral contraceptives.
Croatian: Etinilestradiol se već godinama široko primjenjuje u oralnim kontraceptivima, a norelgestromin je vrlo sličan drugom progesteronu koji se također upotrebljava u nekim oralnim kontraceptivima.
English: The company that markets Evra will perform a study to further investigate the risk of blood clots.
Croatian: Tvrtka koja stavlja lijek Evra na tržište provest će ispitivanje kako bi se dodatno istražio rizik od krvnih ugrušaka.
English: What are the risks associated with Evra?
Croatian: Koji su rizici povezani s lijekom Evra?
English: Using a weekly transdermal patch instead of a daily pill may help the woman to stick to using her contraception appropriately.
Croatian: Primjena tjednog transdermalnog flastera umjesto dnevne tablete može pomoći ženama da na pravilan način upotrebljavaju kontracepciju.
English: Evra is a contraceptive used to prevent pregnancy.
Croatian: Evra je kontraceptiv i koristi se za sprječavanje trudnoće.
English: This is a summary of the European public assessment report (EPAR) for Evra.
Croatian: Ovo je sažetak europskoga javnog izvješća o procjeni (EPAR) lijeka Evra.
English: It contains two active substances: norelgestromin (6 mg) and ethinylestradiol (600 micrograms).
Croatian: Sadrži dvije djelatne tvari: norelgestromin (6 mg) i etinilestradiol (600 mikrograma).
English: It must also not be used together with certain antiviral medicines containing the active substances ombitasvir, paritaprevir, ritonavir and dasabuvir.
Croatian: Ne smije se primjenjivati niti zajedno s određenim protuvirusnim lijekovima koji sadrže djelatne tvari ombitasvir, paritaprevir, ritonavir i dasabuvir.
English: For the first three weeks of the menstrual cycle a new patch should be applied every week, followed by a fourth week, which is patch-free.
Croatian: Tijekom prva tri tjedna menstruacijskog ciklusa svaki tjedan treba staviti novi flaster, a u četvrtom tjednu flaster se ne primjenjuje.
English: Why is Evra approved?
Croatian: Zašto je lijek Evra odobren?
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Evra have also been included in the summary of product characteristics and the package leaflet.
Croatian: Preporuke i mjere opreza kojih se zdravstveni radnici i bolesnici trebaju pridržavati u cilju sigurne i učinkovite primjene lijeka Evra nalaze se u sažetku opisa svojstava i u uputi o lijeku.
English: Other information about Evra
Croatian: Ostale informacije o lijeku Evra
English: Transdermal patches must always be applied on the same day of the week to the buttock, abdomen (belly), upper arm or upper back.
Croatian: Transdermalni flasteri moraju se uvijek stavljati istog dana u tjednu na stražnjicu, trbuh, nadlakticu ili gornji dio leđa.
English: The third study did not compare Evra with any other medicine.
Croatian: U trećem ispitivanju lijek Evra nije uspoređen ni s jednim drugim lijekom.
English: The European Medicines Agency decided that Evra's benefits are greater than its risks for female contraception and recommended that it be given marketing authorisation.
Croatian: Europska agencija za lijekove zaključila je da koristi lijeka Evra nadmašuju s njim povezane rizike za kontracepciju u žena te je preporučila davanje odobrenja za stavljanje lijeka u promet.
English: It must not be used in women who have migraine with aura (unusual visual or other sensory experiences), severe liver problems, liver tumours or a history of liver tumours, some types of cancer or abnormal bleeding from the genital area whose cause has not been diagnosed.
Croatian: Ne smije se primjenjivati u žena koje imaju migrene s aurom (neuobičajenim vizualnim ili drugim osjetilnim iskustvima), ozbiljne probleme s jetrom, tumore jetre ili preboljene tumore jetre, neke vrste raka ili abnormalno krvarenje iz genitalija čiji uzrok nije dijagnosticiran.
English: The Pearl Index is a standard way of measuring the effectiveness of contraceptives, which measures how many unwanted pregnancies occur in 100 woman-years (corresponding to 1,300 cycles), with lower values indicating more effective contraception.
Croatian: Pearlov indeks uobičajen je način mjerenja djelotvornosti kontraceptiva, kojim se utvrđuje koliko je neželjenih trudnoća nastupilo u 100 žena/godina (tj. u 1 300 ciklusa), pri čemu niže vrijednosti upućuju na veću djelotvornost kontracepcije.
English: Overall in the three studies, 15 pregnancies occurred in women taking Evra, 12 of which were the result of a ‘method failure' (when a pregnancy occurs despite the contraceptive being used correctly).
Croatian: Tijekom triju ispitivanja zatrudnjelo je ukupno 15 žena koje su uzimale lijek Evra, od čega je 12 bilo posljedica „neuspjeha metode” (trudnoća je nastupila usprkos pravilnoj primjeni kontraceptiva).
English: It is not intended to provide practical advice on how to use Evra.
Croatian: Svrha sažetka nije davati praktične savjete o primjeni lijeka Evra.
English: For more information about treatment with Evra, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Croatian: Više informacija o liječenju lijekom Evra pročitajte u uputi o lijeku (također dio EPAR-a), odnosno obratite se svojem liječniku ili ljekarniku.
English: Evra works like the pill by changing the body's hormonal balance to prevent ovulation, by altering the cervical mucus and by thinning the endometrium (the lining of the womb).
Croatian: Evra djeluje poput kontracepcijske tablete na način da mijenja hormonsku ravnotežu organizma sprječavajući time ovulaciju te mijenja cervikalnu sluz i stanjuje endometrij (stijenku maternice).
English: What benefit of Evra has been shown in studies?
Croatian: Koje su koristi lijeka Evra dokazane u ispitivanjima?
English: In two studies, Evra was compared with combined oral contraceptives: in one study, the comparator was a ‘monophasic' contraceptive (pill containing the same amounts of active substances over the first three weeks of the treatment cycle) and in the other study, they were ‘triphasic' (with the amount of the active substances in the pills varying through the treatment cycle).
Croatian: U dvama ispitivanjima lijek Evra uspoređen je s kombiniranim oralnim kontraceptivima: u jednom ispitivanju usporedni lijek bio je „monofazni” kontraceptiv (tableta koja sadrži iste količine djelatnih tvari tijekom prva tri tjedna ciklusa tretmana), a u drugom se ispitivanju radilo o „trofaznim” kontraceptivima (količina djelatnih tvari u tabletama varirala je tijekom cijelog ciklusa tretmana).
English: The Pearl Indices for the oral contraceptives were 0.57 (monophasic) and 1.28 (triphasic).
Croatian: Vrijednosti Pearlova indeksa za oralne kontraceptive iznosile su 0,57 (za monofazne) i 1,28 (za trofazne).
English: The most common side effects with Evra (seen in more than 1 patient in 10) were headache, nausea (feeling sick) and breast tenderness.
Croatian: Najčešće nuspojave lijeka Evra (zabilježena u više od 1 na 10 bolesnika) bile su glavobolja, mučnina i bolne dojke.
English: Evra must not be used when a woman has, or has had blood clots in the veins or arteries including a stroke or a heart attack or when a woman has risk factors for blood clots (such as severe high blood pressure, diabetes with damage to the blood vessels, high cholesterol levels, or a family history of thrombosis).
Croatian: Evra se ne smije primjenjivati u žena koje imaju ili su imale krvne ugruške u venama ili arterijama, uključujući moždani ili srčani udar ili u žena u kojih postoji rizik od nastanka krvnih ugrušaka (kao što su vrlo visoki krvni tlak, dijabetes s oštećenjima krvnih žila, visoka razina kolesterola ili tromboza u obiteljskoj anamnezi).
English: Evra is a transdermal patch (a patch that delivers a medicine across the skin).
Croatian: Evra je transdermalni flaster (flaster kojim se lijek isporučuje preko kože).
English: How does Evra work?
Croatian: Kako djeluje Evra?
English: For practical information about using Evra, patients should read the package leaflet or contact their doctor or pharmacist.
Croatian: Praktične informacije o primjeni lijeka Evra bolesnici trebaju pročitati u uputi o lijeku, odnosno trebaju se obratiti svojem liječniku ili ljekarniku.
English: How is Evra used?
Croatian: Kako se Evra koristi?
English: The active substances in Evra are two hormones, ethinylestradiol (an oestrogen) and norelgestromin (a progestogen).
Croatian: Evre su dva hormona, etinilestradiol (estrogen) i norelgestromin (progesteron).
English: For full instructions on how to use Evra, see the package leaflet.
Croatian: Potpune upute o načinu primjene Evre potražite u uputi o lijeku.
English: Evra is a transdermal patch version of ‘the pill' (combined oral contraceptive tablet).
Croatian: Evra je „pilula” (kombinirana kontracepcijska tableta za oralnu primjenu) u obliku transdermalnog flastera.
English: 5 ml (20 mg/ml) 3 vials
Croatian: 5 ml (20 mg/ml) 3 bočice
English: 50 ml (20 mg/ml) 1 vial l t o r
Croatian: 50 ml (20 mg/ml) 1 bočica
English: It can be used for up to 7 consecutive days.
Croatian: Može se primjenjivati do sedam dana uzastopno.
English: In both studies the patients were also receiving G-CSF.
Croatian: U oba ispitivanja bolesnici su primali i G-CSF.
English: Mozobil (plerixafor)
Croatian: Mozobil (pleriksafor)
English: The dose depends on the bodyweight of the patient.
Croatian: Doza lijeka ovisi o tjelesnoj težini bolesnika.
English: • children from 1 year of age who have lymphoma or solid tumours.
Croatian: • djeci starijoj od godinu dana koja imaju limfom ili solidni tumor.
English: Further information on the orphan designation can be found on here: ema.europa.eu/medicines/human/orphan-designations/eu304227.
Croatian: Više informacija o statusu lijeka za rijetku bolest nalazi se ovdje: ema.europa.eu/medicines/human/orphan-designations/eu304227.
English: G-CSF is used on its own for 4 days before Mozobil is added.
Croatian: G-CSF se primjenjuje samostalno četiri dana prije dodavanja lijeka Mozobil.